Evidence map›Paper›PMID 26229981›Full record

ArticleScience advances

The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeability.

Cornelia S Hahn, David W Scott, Xin Xu, Mojtaba Abdul Roda, Gregory A Payne, J Michael Wells, Liliana Viera, Colleen J Winstead, Preston Bratcher, Rolf W Sparidans and 6 more

Open access · goldAbstract read
In one paragraph

Article in Science advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. LC-MS/MS method for proline-glycine-proline and acetylated proline-glycine-proline in human plasma.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Highway toFrontiers in pharmacology · 2022
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Cornelia S HahnDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA ; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
David W ScottDepartment of Cell Biology and Physiology, and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA ; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Xin XuDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Program in Protease and Matrix Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Mojtaba Abdul RodaDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, Netherlands.
Gregory A PayneDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
J Michael WellsDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Program in Protease and Matrix Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Lung Health Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Medical Service at Birmingham VA Medical Center, Birmingham, AL 35233, USA.
Liliana VieraDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Program in Protease and Matrix Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Colleen J WinsteadDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Preston BratcherDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Program in Protease and Matrix Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Rolf W SparidansFaculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, Netherlands.
Frank A RedegeldFaculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, Netherlands.
Patricia L JacksonDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Program in Protease and Matrix Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Lung Health Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Gert FolkertsFaculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, Netherlands.
J Edwin BlalockDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Program in Protease and Matrix Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Lung Health Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Rakesh P PatelDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Program in Protease and Matrix Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Amit GaggarDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Program in Protease and Matrix Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Lung Health Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA ; Medical Service at Birmingham VA Medical Center, Birmingham, AL 35233, USA ; Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
University of Alabama at Birmingham · USUniversity of North Carolina at Chapel Hill · US

Funding

Integrated Training in Cancer Model SystemsT32CA009156 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1985 to 2020
$19.7M
IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
A Novel Proteolytic System of Pulmonary InflammationR01HL102371 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GAGGAR, AMIT · 2010 to 2021
$3.3M
HL-A New Pathway for Neutrophil-induced Airway InflammationR01HL077783 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2006 to 2016
$3.2M
Effect of Macrolide Treatment on a Novel Pathway of Neutrophilic Inflammation inR01HL090999 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2007 to 2010
$1.5M
Role of hemoglobin b93cys residue in nitric oxide bioactivityR01HL092624 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PATEL, RAKESH P. · 2010 to 2013
$1.5M
Therapeutics for Chronic Lung Diseases: Antagonists of PGP, Chemokines and CXCRR01HL087824 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2009 to 2010
$823k
The Role of PGP in COPD-associated Pulmonary HypertensionK08HL123940 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WELLS, JAMES MICHAEL · 2014 to 2018
$744k
Prolyl Endopeptidase-Mediated Matrix Remodeling and Inflammation in COPDI01BX001756 · VA · BIRMINGHAM VA MEDICAL CENTER · PI GAGGAR, AMIT · 2015 to 2018
–
BLRD VA I01 BX001756NCI NIH HHS T32 CA009156NHLBI NIH HHS K08 HL123940NHLBI NIH HHS R01 HL077783NHLBI NIH HHS R01 HL087824NHLBI NIH HHS R01 HL090999NHLBI NIH HHS R01 HL092624NHLBI NIH HHS R01 HL102371NIAID NIH HHS T32 AI007051
6 · The paper itself

Abstract

The compartmentalization and transport of proteins and solutes across the endothelium is a critical biologic function altered during inflammation and disease, leading to pathology in multiple disorders. The impact of tissue damage and subsequent extracellular matrix (ECM) fragmentation in regulating this process is unknown. We demonstrate that the collagen-derived matrikine acetylated proline-glycine-proline (N-α-PGP) serves as a critical regulator of endothelial permeability. N-α-PGP activates human endothelial cells via CXC-chemokine receptor 2 (CXCR2), triggering monolayer permeability through a discrete intracellular signaling pathway. In vivo, N-α-PGP induces local vascular leak after subcutaneous administration and pulmonary vascular permeability after systemic administration. Furthermore, neutralization of N-α-PGP attenuates lipopolysaccharide-induced lung leak. Finally, we demonstrate that plasma from patients with acute respiratory distress syndrome (ARDS) induces VE-cadherin phosphorylation in human endothelial cells, and this activation is attenuated by N-α-PGP blockade with a concomitant improvement in endothelial monolayer impedance. These results identify N-α-PGP as a novel ECM-derived matrikine regulating paracellular permeability during inflammatory disease and demonstrate the potential to target this ligand in various disorders characterized by excessive matrix turnover and vascular leak such as ARDS.

Identifiers

PMID26229981
PMCPMC4517288
OpenAlexW2110874917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.